What is Chylothorax?
Chylothorax is a type of pleural effusion — a fluid build-up inside the chest cavity — in which the fluid is chyle: the fat-rich, milky-white lymphatic fluid produced in the intestinal tract during digestion. When chyle leaks into the pleural space (the space between the lungs and the chest wall), it compresses the lungs and causes progressive, potentially life-threatening breathing difficulty.
The word comes from the Greek chylos (juice) and thorax (chest). It is one of the most challenging thoracic conditions in small animal surgery — not because the surgery itself is technically impossible, but because chylothorax tends to recur if the underlying anatomy is not addressed comprehensively with a combined three-procedure approach.
Untreated chylothorax leads to fibrosing pleuritis — permanent scarring of the pleural surfaces that restricts lung expansion even after the chyle is drained. This complication is largely irreversible and is the primary reason early surgical referral is recommended. Don't wait for medical management to fail for months before referring for surgical evaluation.
A Brief History of the Lymphatic System
"The lymphatic system was first discovered in a dog." — Gaspar Aselli, Italian Anatomist (1581–1626), De Lactis Venis, 1627
In 1622, Italian anatomist Gaspar Aselli made a landmark discovery while dissecting a dog — the lacteal vessels of the intestines, the lymphatic capillaries that carry dietary fat. He described these as "milky veins" and published his findings in De Lactis Venis in 1627. The thoracic duct — the largest lymphatic vessel in the body — was characterised shortly after by Jean Pecquet in 1651.
Chylothorax has been recognised as a clinical entity for over a century. Even today it remains an area of active research, with ongoing refinement of surgical technique and accumulating evidence for the combined approach. The highly variable anatomy of the thoracic duct makes every surgical case unique.
The three roles of the lymphatic system:
- Maintain fluid balance — returning interstitial fluid to the circulation
- Generate immune response — lymphocyte trafficking and antigen presentation
- Absorb and transport dietary fats — from the gut to the venous circulation
Anatomy — The Thoracic Duct & Lymphatic Pathway
Understanding chylothorax requires understanding where chyle comes from and how it normally travels to the venous circulation:
The thoracic duct has extraordinarily variable anatomy in dogs and cats — there may be 1–4 main trunks, and they may cross from right to left at any level within the chest. This is why CT lymphangiography before surgery is invaluable for pre-operative planning. The thoracic duct is NOT a single white tubular structure — it is typically a plexus of small, clear to yellow lymphatic channels, often barely visible to the naked eye.
Pathophysiology — How Chyle Accumulates
Chyle accumulates in the pleural space when the thoracic duct is disrupted, obstructed, or under abnormally high pressure. The mechanisms include:
- Increased lymph production / elevated venous pressure: Elevated central venous pressure (from heart failure, cranial mediastinal masses, or pericardial disease) increases the pressure gradient against which the thoracic duct must empty. This can cause the duct to develop permeable 'lymphangiectasia' and leak.
- Direct rupture: Trauma can directly lacerate the thoracic duct — these cases have the best prognosis with medical management alone.
- Obstruction: Cranial mediastinal masses (lymphoma, thymoma), granulomas, or neoplasia obstruct the thoracic duct, causing upstream back-pressure and leakage.
- Idiopathic: In most cases in dogs and cats, no underlying cause is found despite thorough work-up — termed idiopathic chylothorax. This is the most common presentation.
Once chyle enters the pleural space, it triggers a cycle of chronic inflammation. The lipid-laden macrophages and the repeated mechanical stretch from effusion cause progressive fibrosis of the pleural surfaces — fibrosing pleuritis — which permanently restricts lung expansion even after drainage. This makes early surgical intervention critical.
Causes & Breed Predispositions
| Cause | Notes |
|---|---|
| Idiopathic | Most common in dogs and cats — no underlying cause identified despite full work-up. Surgical management is the standard of care. |
| Right-sided heart failure | Elevated venous pressure → increased thoracic duct back-pressure → leakage. Diagnose and treat cardiac disease first. Echocardiogram required pre-op. |
| Pericardial effusion | Elevated right-heart filling pressure — pericardectomy alone can resolve chylothorax in some cases. |
| Cranial mediastinal mass | Lymphoma and thymoma are the most common. Obstruction of thoracic duct. Treat primary disease first; surgical options guided by tumour type. |
| Lung lobe torsion | Obstruction of lymphatic drainage from the affected lobe. Lung lobectomy resolves both conditions. |
| Trauma | Direct thoracic duct laceration. These cases often resolve with medical management (4–6 weeks). Best prognosis without surgery. |
| Heartworm disease | Obstruction of lymphatic drainage. Most relevant in heartworm-endemic regions. |
| Fungal granuloma | Histoplasma, Blastomyces — most common in geographic endemic areas. |
Breed Predispositions
In dogs: Afghan Hounds are dramatically over-represented — idiopathic chylothorax is almost a breed disease in Afghans. Other predisposed breeds include Shiba Inus, Greyhounds, and Labrador Retrievers. Any large breed dog can be affected.
In cats: any breed can be affected. Older cats should always be screened for lymphoma and thymoma as the underlying cause before planning surgical intervention — thoracic CT and cytology of fluid are essential.
Clinical Signs
Clinical signs depend on the rate of chyle accumulation and the degree of lung compression. Signs are often progressive over weeks:
Increased respiratory rate — often the first sign noticed. May be subtle initially.
Laboured breathing. Open-mouth breathing in cats is always an emergency.
Progressive — often dismissed as 'getting older.' Key early sign.
Chronic chyle loss depletes protein, fat-soluble vitamins (A, D, E, K), and lymphocytes — causing immunosuppression.
Fluid attenuates auscultation — ventral dullness on percussion.
General malaise from hypoxia, protein loss, and immunosuppression.
Cats do not breathe through their mouths unless in severe respiratory distress. If your cat is breathing with its mouth open, this is a life-threatening emergency. Go directly to VERG Brooklyn — (718) 522-9400 — open 24 hours a day, 7 days a week. Do not wait for a morning appointment.
Diagnostics
Pleural Fluid Analysis — The Cornerstone of Diagnosis
Chylothorax cannot be diagnosed from radiographs alone — pleural fluid analysis is required. Chylous effusion has specific characteristics:
| Parameter | Chylous Effusion Finding |
|---|---|
| Gross appearance | Milky white or pink-tinged (from chylomicrons + red blood cells). Clears on feeding a low-fat diet. |
| Triglycerides (effusion) | >100 mg/dL; OR effusion triglycerides > serum triglycerides — the most reliable test |
| Cholesterol:Triglyceride ratio | <1 (chylous) vs >1 (pseudochylous — cholesterol crystals from chronic inflammation) |
| Cytology | Predominantly small lymphocytes (acute/recent onset) or non-degenerate neutrophils + macrophages (chronic, lipid-depleted) |
| Sudan Red staining | Positive — confirms presence of chylomicrons (fat droplets) |
| Protein | High — typically >2.5 g/dL |
| Clears on centrifugation? | No (chyle — fat stays in suspension) vs Yes (pseudochyle — cholesterol crystals pellet out) |
In chronic or lipid-depleted patients (e.g. those fed a strict low-fat diet for weeks), the fluid may appear clear or serosanguineous rather than milky. Chylomicrons are reduced when there is no dietary fat to absorb. Triglyceride comparison to serum is still the most reliable diagnostic test regardless of gross appearance.
Advanced Diagnostics
- Thoracic radiographs: Confirm pleural effusion — homogeneous fluid opacity with meniscus sign at costophrenic angles. Cannot distinguish chyle from other effusion types.
- Echocardiography: Rules out right-sided heart failure, pericardial effusion, and cranial mediastinal masses as the primary cause. Essential before surgery.
- CT scan of thorax: Evaluates mediastinal structures, lymph node size, primary masses, extent of pleural changes, and thoracic duct anatomy.
- CT lymphangiography: Gold-standard for pre-operative thoracic duct mapping. Iohexol contrast is injected into a mesenteric lymph node, and CT imaging immediately after visualises the thoracic duct pathway, number of trunks, and location of any leakage points. Performed at VERG Brooklyn before thoracic duct ligation surgery.
Medical Management — and Why It Often Fails
Medical management is the appropriate first step, particularly when an underlying cause has been identified (e.g. congestive heart failure, mediastinal mass) or when the diagnosis is recent (under 2–4 weeks). Medical options:
- Low-fat diet: Reduces chyle production by decreasing dietary fat. Hill's i/d or homemade ultra-low-fat diets. Medium-chain triglyceride (MCT) oil can supplement calories — MCTs are absorbed directly into the portal circulation, bypassing the lacteals.
- Rutin supplementation: A bioflavonoid antioxidant reported anecdotally to increase lymphatic absorption in cats. Evidence is weak but side-effect free. Dose: 50 mg/kg q8h PO.
- Repeated thoracocentesis: Provides symptomatic relief and respiratory stabilisation but does not treat the underlying cause. Each tap removes protein and lymphocytes, contributing to progressive nutritional and immunological depletion.
- Octreotide: A somatostatin analogue that may reduce intestinal lymph flow. Limited veterinary evidence; used in some refractory cases.
Medical management resolves idiopathic chylothorax in approximately 1 in 4–5 dogs and cats. For most idiopathic cases, surgery is recommended within 4–8 weeks of diagnosis if medical management has not achieved resolution — before fibrosing pleuritis becomes established and irreversible.
Surgical Treatment — The Gold Standard Combined Approach
Dr. Morgan uses the combined three-procedure approach, which achieves the highest published resolution rates in the veterinary surgical literature. All three procedures are performed in the same anaesthetic event.
Thoracic Duct Ligation (TDL)
The primary surgical procedure. All lymphatic vessels running alongside the aorta in the caudal mediastinum are mass-ligated at the level of the diaphragm, interrupting chyle flow through the thoracic duct and forcing the development of new, more efficient lymphaticovenous connections that empty directly into the venous system.
Approach: Right lateral intercostal thoracotomy (9th–10th ICS) or thoracoscopic (preferred). Under direct vision, lymphatic tissue alongside the aorta is mass-ligated using surgical clips or absorbable suture. CT lymphangiography performed before and sometimes intraoperatively confirms complete ligation.
The thoracic duct is typically a plexus of small, clear-to-yellow channels barely visible to the naked eye. Methylene blue or iohexol injected into a mesenteric lymph node at surgery stains the ducts and confirms complete ligation by demonstrating absence of blue dye in the chest post-ligation.
Subtotal Pericardectomy
The pericardium is the fibrous sac surrounding the heart. Even without overt pericardial effusion, elevated pericardial pressure contributes to elevated right-heart venous pressure — which in turn increases thoracic duct back-pressure. Removing the ventral pericardium (subtotal pericardectomy) reduces this venous back-pressure and facilitates the development of new lymphaticovenous connections.
Published evidence (Fossum et al. 2004; Allman et al.) consistently shows that adding pericardectomy to TDL improves resolution rates from approximately 50–60% (TDL alone) to 80–85% (TDL + pericardectomy). Subtotal pericardectomy is now considered a mandatory component of the combined approach — not an optional add-on.
Cisterna Chyli Ablation (CCA)
The cisterna chyli is the abdominal lymphatic reservoir from which the thoracic duct originates. Ablation (disruption) of the cisterna chyli via a transdiaphragmatic or laparoscopic approach reduces the driving pressure of lymph into the thoracic duct system.
Technique: The diaphragm is incised (transdiaphragmatic approach) or laparoscopic portals are placed. The cisterna chyli is identified just ventral to the aorta at the diaphragm and is suture-ligated or fulgurated (electrocautery). Performed as part of the same anaesthetic event as TDL and pericardectomy.
Thoracoscopic vs Open Thoracotomy
Dr. Morgan performs thoracic duct ligation thoracoscopically wherever possible — using 3–4 small (5–10 mm) portal incisions rather than a full lateral thoracotomy.
- 8–12 cm lateral chest incision
- Rib retraction — significant pain
- Longer recovery
- Required for severe adhesions
- 3–4 × 10 mm portal incisions
- Significantly less post-op pain
- Faster recovery, earlier discharge
- Equivalent resolution rates
- Magnified intraoperative visualisation
Outcomes & Prognosis
| Treatment | Resolution Rate | Notes |
|---|---|---|
| Medical management alone | ~20–25% | Best for trauma-induced or secondary chylothorax with a treatable primary cause |
| TDL alone | ~50–60% | Historical approach; resolution rate unacceptably low for most cases |
| TDL + Pericardectomy | ~70–75% | Significant improvement; now considered minimum standard |
| TDL + Pericardectomy + CCA | ~80–85% | Current gold standard. Best outcomes — recommended by Dr. Morgan |
| Surgery before fibrosing pleuritis | Significantly better | Early surgical referral is strongly recommended. Do not delay. |
What Happens If Left Untreated?
Untreated chylothorax causes progressive lung compression and respiratory failure. Even if the primary cause is addressed, chronic chyle in the pleural space leads to fibrosing pleuritis — permanent scarring that restricts lung expansion regardless of drainage. This is the most feared complication of delayed treatment and is largely irreversible, significantly impacting quality of life and long-term prognosis even after eventual surgical resolution of the chylothorax itself.
Literature
- Fossum TW et al. (2004) — Combined thoracic duct ligation and pericardectomy in 13 dogs with chylothorax. JAVMA
- Allman DA et al. — Outcome of thoracoscopic thoracic duct ligation and pericardectomy in dogs with chylothorax. Veterinary Surgery
- McAnulty JF — Prospective comparison of cisterna chyli ablation to pericardectomy for treatment of spontaneously occurring idiopathic chylothorax in the dog. Veterinary Surgery (2011)
- Carobbi B, White RA — Outcome of surgery for idiopathic chylothorax in 9 dogs and 10 cats. Veterinary Record (2010)
Key Takeaways for Pet Owners
It's the Milky Fluid
The fluid in your pet's chest is chyle — the dietary fat-rich lymphatic fluid from the gut. It builds up when the thoracic duct leaks.
Medical Treatment Usually Fails
Low-fat diets and supplements resolve chylothorax in only ~20–25% of cases. Most pets need surgery.
Earlier Surgery = Better Outcome
Delaying surgery allows fibrosing pleuritis to develop — a permanent, largely irreversible scarring of the lungs. Don't wait too long.
Surgery Works ~85% of the Time
The combined approach (TDL + pericardectomy + cisterna chyli ablation) resolves chylothorax in approximately 85% of patients. Keyhole (thoracoscopic) surgery preferred.
Questions to Ask at Your Referral Appointment
- Has an underlying cause been ruled out (echocardiogram, CT scan, cytology for lymphoma)?
- Is my pet a candidate for thoracoscopic (keyhole) surgery vs open thoracotomy?
- Will all three procedures (TDL + pericardectomy + cisterna chyli ablation) be performed?
- What is the plan if chylothorax does not resolve after surgery?
- How will we know surgery has worked? (repeat thoracocentesis at 4–6 weeks)
References & Further Reading
- Fossum TW et al. (2004). Thoracic duct ligation and pericardectomy for treatment of idiopathic chylothorax. JAVMA 224(10):1528–35.
- Allman DA, Radlinsky MG, Ralph AG, Rawlings CA (2010). Thoracoscopic thoracic duct ligation and thoracoscopic pericardectomy for treatment of chylothorax in dogs. Veterinary Surgery 39(1):21–7.
- McAnulty JF (2011). Prospective comparison of cisterna chyli ablation to pericardectomy. Veterinary Surgery 40(7):815–22.
- Carobbi B, White RA (2010). Outcome of surgery for idiopathic chylothorax in 9 dogs and 10 cats. Veterinary Record 166(5):148–52.
- Aselli G (1627). De Lactis Venis. Milan. [Historical reference — discovery of lacteals in a dog]